MedPath

Detecting the SLN by using methylene blue in patients affected by cervical cancer in the primitive stages; who were treated by surgical approaches in gynaecology wards in Baghiatallah Azam and Imam Khomeini hospitals

Not Applicable
Conditions
Radical hysterectomy and lymphadenectomy/Cervical cancer.
Registration Number
IRCT201205069656N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
32
Inclusion Criteria

The patients affected by cervical cancer (Ib1-IIa stage) who are candidate for radical hysterectomy and lymphadenectomy will enter in this study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Biopsy/pathology result. Timepoint: 10 days. Method of measurement: Biopsy/Microscope.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath